TNF-α reduces g0s2 expression and stimulates lipolysis through PPAR-γ inhibition in 3T3-L1 adipocytes

Cytokine

Volumn 69, Issue 2, 2014, Pages 196-205

  Jin, Dan ^a   Sun, Jun ^a   Huang, Jing ^a   He, Yiduo ^a   Yu, An ^a   Yu, Xiaoling ^a   Yang, Zaiqing ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adipocyte; G0S2; Lipolysis; PPAR ; TNF

Indexed keywords

ADIPONECTIN; G0 G1 SWITCH GENE 2 PROTEIN; HORMONE SENSITIVE LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; ABHD5 PROTEIN, MOUSE; CELL CYCLE PROTEIN; G0S2 PROTEIN, MOUSE; GLYCEROL; PROTEASOME; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ADIPONECTIN GENE; ADIPOSE TRIGYCERIDE LIPASE GENE; ARTICLE; CELL LEVEL; CGI 58 GENE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; G0 G1 SWITCH GENE 2 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HORMONE SENSITIVE LIPASE GENE; LIPOLYSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SHAPE; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; PROMOTER REGION;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; 3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL CYCLE PROTEINS; CELL SHAPE; DOWN-REGULATION; GLYCEROL; LIPASE; LIPOLYSIS; MICE; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903648721     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.06.005     Document Type: Article

References (44)

1. Lass A., Zimmermann R., Haemmerle G., Riederer M., Schoiswohl G., Schweiger M., et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 2006, 3:309-319.
2. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306:1383-1386.
3. Zimmermann R., Lass A., Haemmerle G., Zechner R. Fate of fat: the role of adipose triglyceride lipase in lipolysis. Biochim Biophys Acta 2009, 1791:494-500.
4. Zechner R., Kienesberger P.C., Haemmerle G., Zimmermann R., Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 2009, 50:3-21.
5. Watt M.J., Steinberg G.R. Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem J 2008, 414:313-325.
6. Yang X., Lu X., Lombes M., Rha G.B., Chi Y.I., Guerin T.M., et al. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010, 11:194-205.
7. Zandbergen F., Mandard S., Escher P., Tan N.S., Patsouris D., Jatkoe T., et al. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J 2005, 392:313-324.
8. Bezaire V., Mairal A., Anesia R., Lefort C., Langin D. Chronic TNFalpha and cAMP pre-treatment of human adipocytes alter HSL, ATGL and perilipin to regulate basal and stimulated lipolysis. FEBS Lett 2009, 583:3045-3049.
9. Langin D., Dicker A., Tavernier G., Hoffstedt J., Mairal A., Ryden M., et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 2005, 54:3190-3197.
10. Cornaciu I., Boeszoermenyi A., Lindermuth H., Nagy H.M., Cerk I.K., Ebner C., et al. The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively. PLoS ONE 2011, 6:e26349.
11. Lu X., Yang X., Liu J. Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2. Cell Cycle 2010, 9:2719-2725.
12. Ahmadian M., Duncan R.E., Varady K.A., Frasson D., Hellerstein M.K., Birkenfeld A.L., et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes 2009, 58:855-866.
13. Ahmadian M., Abbott M.J., Tang T., Hudak C.S., Kim Y., Bruss M., et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab 2011, 13:739-748.
14. Radner F.P., Streith I.E., Schoiswohl G., Schweiger M., Kumari M., Eichmann T.O., et al. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 2010, 285:7300-7311.
15. Caviglia J.M., Betters J.L., Dapito D.H., Lord C.C., Sullivan S., Chua S., et al. Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity. J Lipid Res 2011, 52:2032-2042.
16. Ahn J., Oh S.-A., Suh Y., Moeller S.J., Lee K. Porcine G0/G1 switch gene 2 (G0S2) expression is regulated during adipogenesis and short-term in-vivo nutritional interventions. Lipids 2013.
17. Heckmann B.L., Zhang X., Xie X., Liu J. The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond. Biochimica et Biophysica Acta (BBA) - Mole Cell Biol Lipids 2013, 1831:276-281.
18. Russell L., Forsdyke D.R. A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 1991, 10:581-591.
19. Yang X., Zhang X., Heckmann B.L., Lu X., Liu J. Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-alpha (TNF-alpha)-induced lipolysis in adipocytes. J Biol Chem 2011, 286:40477-40485.
20. Schweiger M., Paar M., Eder C., Brandis J., Moser E., Gorkiewicz G., et al. G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase. J Lipid Res 2012.
21. Mehlem A., Hagberg C.E., Muhl L., Eriksson U., Falkevall A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc 2013, 8:1149-1154.
22. Li L., Yang G., Shi S., Yang M., Liu H., Boden G. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009, 45:12-19.
23. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
24. Chen X., Xun K., Chen L., Wang Y. TNF-alpha, a potent lipid metabolism regulator. Cell Biochem Funct 2009, 27:407-416.
25. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40:185-194.
26. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., et al. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 2005, 240:43-49.
27. Zhang H.H., Halbleib M., Ahmad F., Manganiello V.C., Greenberg A.S. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002, 51:2929-2935.
28. Rahn Landstrom T., Mei J., Karlsson M., Manganiello V., Degerman E. Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP. Biochem J 2000, 346(2):337-343.
29. Souza S.C., de Vargas L.M., Yamamoto M.T., Lien P., Franciosa M.D., Moss L.G., et al. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 1998, 273:24665-24669.
30. Souza S.C., Palmer H.J., Kang Y.H., Yamamoto M.T., Muliro K.V., Paulson K.E., et al. TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem 2003, 89:1077-1086.
31. Rodriguez-Cuenca S., Carobbio S., Velagapudi V.R., Barbarroja N., Moreno-Navarrete J.M., Tinahones F.J., et al. Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol 2012, 32:1555-1565.
32. Kershaw E.E., Schupp M., Guan H.P., Gardner N.P., Lazar M.A., Flier J.S. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metabol 2007, 293:E1736-E1745.
33. Huang J.V., Greyson C.R., Schwartz G.G. PPAR-gamma as a therapeutic target in cardiovascular disease: evidence and uncertainty. J Lipid Res 2012, 53:1738-1754.
34. Choi J.H., Banks A.S., Kamenecka T.M., Busby S.A., Chalmers M.J., Kumar N., et al. Antidiabetic actions of a non-agonist PPARgamma ligand blocking Cdk5-mediated phosphorylation. Nature 2011, 477:477-481.
35. Tan G.D., Savage D.B., Fielding B.A., Collins J., Hodson L., Humphreys S.M., et al. Fatty acid metabolism in patients with PPARgamma mutations. J Clin Endocrinol Metabol 2008, 93:4462-4470.
36. Sun X.J., Goldberg J.L., Qiao L.Y., Mitchell J.J. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 1999, 48:1359-1364.
37. Connor A.M., Mahomed N., Gandhi R., Keystone E.C., Berger S.A. TNFalpha modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res Therapy 2012, 14:R62.
38. Kettelhut I.C., Wing S.S., Goldberg A.L. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev 1988, 4:751-772.
39. Jariel-Encontre I., Pariat M., Martin F., Carillo S., Salvat C., Piechaczyk M. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem 1995, 270:11623-11627.
40. Tesz G.J., Guilherme A., Guntur K.V., Hubbard A.C., Tang X., Chawla A., et al. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J Biolog Chem 2007, 282:19302-19312.
41. Laurencikiene J., van Harmelen V., Arvidsson Nordstrom E., Dicker A., Blomqvist L., Naslund E., et al. NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes. J Lipid Res 2007, 48:1069-1077.
42. Lien C.C., Au L.C., Tsai Y.L., Ho L.T., Juan C.C. Short-term regulation of tumor necrosis factor-alpha-induced lipolysis in 3T3-L1 adipocytes is mediated through the inducible nitric oxide synthase/nitric oxide-dependent pathway. Endocrinology 2009, 150:4892-4900.
43. Ryden M., Arvidsson E., Blomqvist L., Perbeck L., Dicker A., Arner P. Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 2004, 318:168-175.
44. Ryden M., Dicker A., van Harmelen V., Hauner H., Brunnberg M., Perbeck L., et al. Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J Biol Chem 2002, 277:1085-1091.